pembrolizumab,trastuzumab deruxtecan
daiichi sankyo,astrazeneca,merck
['pcr-mib', 'mibc', 'pembro']
come by the posters at midday to discuss the results from pcr-mib pembro/chemort in mibc - 28 patients rx curative intent was it safe?
was it active?
worth exploring in a phase 3 study? #esmo22 
An Australian oncologist with an interest in GU malignancies, phase 1 trials, cycling and having fun with the family